{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T06:45:56Z","timestamp":1774075556918,"version":"3.50.1"},"reference-count":26,"publisher":"Japanese Society of Internal Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,3,15]]},"DOI":"10.2169\/internalmedicine.5964-25","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T22:07:15Z","timestamp":1756332435000},"page":"873-877","source":"Crossref","is-referenced-by-count":0,"title":["Localized Stage Plasmablastic Lymphoma with Ulcerative Colitis in Long-term Remission after Chemoradiotherapy"],"prefix":"10.2169","volume":"65","author":[{"given":"Kentaro","family":"Hara","sequence":"first","affiliation":[{"name":"Division of Hematology and Clinical Laboratory Medicine, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rina","family":"Hosoda","sequence":"additional","affiliation":[{"name":"Division of Hematology and Clinical Laboratory Medicine, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Maegaki","sequence":"additional","affiliation":[{"name":"Division of Hematology and Clinical Laboratory Medicine, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaka","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Division of Hematology and Clinical Laboratory Medicine, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzuru","family":"Hosoda","sequence":"additional","affiliation":[{"name":"Division of Hematology and Clinical Laboratory Medicine, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Ikebuchi","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Nephrology, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kuwamoto","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Tottori University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Kawamura","sequence":"additional","affiliation":[{"name":"Division of Hematology and Clinical Laboratory Medicine, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Delecluse HJ, Anagnostopoulos I, Dallenbach F, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 89: 1413-1420, 1997.","DOI":"10.1182\/blood.V89.4.1413"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Castillo J, Pantanowitz L, Dezube BJ. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am J Hematol 83: 804-809, 2008.","DOI":"10.1002\/ajh.21250"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Liu M, Liu B, Liu B, et al. Human immunodeficiency virus-negative plasmablastic lymphoma: a comprehensive analysis of 114 cases. Oncol Rep 33: 1615-1620, 2015.","DOI":"10.3892\/or.2015.3808"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Morscio J, Dierickx D, Nijs J, et al. Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases. Am J Surg Pathol 38: 875-886, 2014.","DOI":"10.1097\/PAS.0000000000000234"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Castillo JJ, Bibas M, Miranda RN. The biology and treatment of plasmablastic lymphoma. Blood 125: 2323-2330, 2015.","DOI":"10.1182\/blood-2014-10-567479"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Zanelli M, Ragazzi M, Valli R, et al. Unique presentation of a plasmablastic lymphoma superficially involving the entire large bowel. Pathol Res Pract 211: 1030-1033, 2015.","DOI":"10.1016\/j.prp.2015.09.012"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Teruya-Feldstein J, Chiao E, Filippa DA, et al. CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol 15: 1673-1679, 2004.","DOI":"10.1093\/annonc\/mdh399"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ogiyama H, Murayama Y, Tsutsui S, et al. Plasmablastic lymphoma occurring in ulcerative colitis during treatment with immunosuppressive therapy. Clin J Gastroenterol 16: 198-205, 2023.","DOI":"10.1007\/s12328-023-01754-5"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Muller M, Broseus J, Guilloteau A, et al. Lymphoma in patients with inflammatory bowel disease: a multicentre collaborative study between GETAID and LYSA. J Crohns Colitis 18: 533-539, 2024.","DOI":"10.1093\/ecco-jcc\/jjad177"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yashiro M. Ulcerative colitis-associated colorectal cancer. World J Gastroenterol 20: 16389-16397, 2014.","DOI":"10.3748\/wjg.v20.i44.16389"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Zamani M, Alizadeh-Tabari S, Murad MH, et al. Meta-analysis: risk of lymphoma in patients with inflammatory bowel disease in population-based cohort studies. Aliment Pharmacol Ther 60: 1264-1275, 2024.","DOI":"10.1111\/apt.18277"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Beigel F, Steinborn A, Schnitzler F, et al. Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies. Pharmacoepidemiol Drug Saf 23: 735-744, 2014.","DOI":"10.1002\/pds.3621"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Beaugerie L, Brousse N, Bouvier AM, et al.; the CESAME Study Group. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet 374: 1617-1625, 2009.","DOI":"10.1016\/S0140-6736(09)61302-7"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Cohen JI, Kimura H, Nakamura S, Ko YH, Jaffe ES. Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008. Ann Oncol 20: 1472-1482, 2009.","DOI":"10.1093\/annonc\/mdp064"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127: 2375-2390, 2016.","DOI":"10.1182\/blood-2016-01-643569"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Jessa R, Chien N, Villa D, et al. Clinicopathological characteristics and long-term outcomes of plasmablastic lymphoma in British Columbia. Br J Haematol 199: 230-238, 2022.","DOI":"10.1111\/bjh.18399"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Sokol H, Beaugerie L, Maynadi\u00e9 M, et al.; the CESAME Study Group. Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease. Inflamm Bowel Dis 18: 2063-2071, 2012.","DOI":"10.1002\/ibd.22889"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Dayharsh GA, Loftus EV Jr, Sandborn WJ, et al. Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine. Gastroenterology 122: 72-77, 2002.","DOI":"10.1053\/gast.2002.30328"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Castillo JJ, Winer ES, Stachurski D, et al. HIV-negative plasmablastic lymphoma: not in the mouth. Clin Lymphoma Myeloma Leuk 11: 185-189, 2011.","DOI":"10.1016\/j.clml.2011.03.008"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Horwitz SM, Zelenetz AD, Gordon LI, et al. NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016. J Natl Compr Canc Netw 14: 1067-1079, 2016.","DOI":"10.6004\/jnccn.2016.0117"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Castillo JJ, Furman M, Beltr\u00e1n BE, et al. Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy. Cancer 118: 5270-5277, 2012.","DOI":"10.1002\/cncr.27551"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Castillo JJ, Winer ES, Stachurski D, et al. Prognostic factors in chemotherapy-treated patients with HIV-associated plasmablastic lymphoma. Oncologist 15: 293-299, 2010.","DOI":"10.1634\/theoncologist.2009-0304"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Li YJ, Li JW, Chen KL, et al. HIV-negative plasmablastic lymphoma: report of 8 cases and a comprehensive review of 394 published cases. Blood Res 55: 49-56, 2020.","DOI":"10.5045\/br.2020.55.1.49"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Cattaneo C, Finel H, McQuaker G, Vandenberghe E, Rossi G, Dreger P. Autologous hematopoietic stem cell transplantation for plasmablastic lymphoma: the European Society for Blood and Marrow Transplantation experience. Biol Blood Marrow Transplant 21: 1146-1147, 2015.","DOI":"10.1016\/j.bbmt.2015.03.008"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Al-Malki MM, Castillo JJ, Sloan JM, Re A. Hematopoietic cell transplantation for plasmablastic lymphoma: a review. Biol Blood Marrow Transplant 20: 1877-1884, 2014.","DOI":"10.1016\/j.bbmt.2014.06.009"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Hess BT, Giri A, Park Y, et al. Outcomes of patients with limited-stage plasmablastic lymphoma: a multi-institutional retrospective study. Am J Hematol 98: 300-308, 2023.","DOI":"10.1002\/ajh.26784"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/6\/65_5964-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T03:33:55Z","timestamp":1774064035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/6\/65_5964-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,15]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5964-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,15]]},"article-number":"5964-25"}}